Jun Tang, Ph.D.

Senior Research Analyst

Jun joined the Cancer Research Institute in January 2017 as a senior research analyst in the Institute’s Clinical Accelerator program, where he is using his scientific training to help accelerate the translation of new cancer immunotherapy combinations from labs to the clinic.

Prior to CRI, Jun spent more than a decade as a scientist in immunology and biomedical engineering. He received his bachelor degree in bioengineering in 2005 and a master degree in biochemistry in 2008 in China. After that, he moved to the U.S. and received his Ph.D. in 2014 from Icahn School of Medicine at Mount Sinai, where he developed nanomaterial-based immunotherapies for cardiovascular diseases and cancer. He then pursued a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in 2015, where he developed cancer immunotherapies for solid tumors and imaging probes for nuclear oncological imaging. Jun has published more than 28 peer-reviewed papers, given over ten conference presentations, won eight research awards, and filed one patent.

Jun strongly believes that cancer immunotherapy will revolutionize cancer treatment and save millions of lives.

Selected publications:

Changing the Way Cancer is Treated and Cured

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

*Immunotherapy results may vary from patient to patient.

Top